RET and medullary thyroid gland carcinoma: NF-κB is constitutively active in MTC through the RET-induced phosphorylation, ubiquitination, and proteosomal degradation of inhibitors of NF-κB (IkB), which allows NF-κB to enter the nucleus and bind to DNA [65].